Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Avacta has signed an analytical services agreement with Pall, a provider filtration, separation and purification services to biopharmaceutical developers.
Subscribe to our email newsletter
The tie up allows Pall to use the services of Avacta and market joint services in North America, and in other regions globally where Avacta is not currently represented.
The combined services are aimed at reducing drug development risk by giving customers greater insight into the effects of their manufacturing processes.
Avacta and Pall expect to offer analytical service to the developers of biological drugs in reducing the costs of drug development through improved compound screening and optimization of manufacturing and purification conditions
The services will be delivered through Pall’s Scientific Laboratories Services global network and through Avacta at its laboratories in York, UK.
Pall senior vice president Ken Frank said they believe that they will help their customers, with better information provided by these services, to improve their decision making and save valuable time in the critically important job of getting new products to market.